Archives

  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fl...

    2025-10-30

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fluorescent Protein mRNA for Robust Reporter Gene Expression

    Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic mRNA of ~996 nt encoding mCherry, a red fluorescent protein with peak emission at 610 nm. It features a Cap 1 structure for enhanced translation and mammalian mimicry, and incorporates 5-methylcytidine and pseudouridine to minimize innate immune response and maximize stability. Supplied at ~1 mg/mL in sodium citrate (pH 6.4), this mRNA is designed for use as a robust reporter in molecular and cell biology. Storage at ≤ -40°C is recommended to maintain full activity and integrity (EZ Cap™ mCherry mRNA (5mCTP, ψUTP)).

    Biological Rationale

    Reporter gene mRNAs are essential in molecular biology for visualizing gene expression, monitoring cellular processes, and verifying transfection efficiency. mCherry is a monomeric red fluorescent protein derived from DsRed of Discosoma sp., with excitation/emission maxima of 587/610 nm, respectively (FPbase: mCherry). Synthetic mRNAs encoding fluorescent proteins enable transient but high-level protein expression without genomic integration, thus reducing off-target effects and regulatory complexity. Modifications such as 5-methylcytidine and pseudouridine further enhance RNA stability and reduce innate immune activation, which is critical for applications in sensitive cell types and in vivo protocols (Roach 2024).

    Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) integrates several molecular design elements for optimal performance:

    • Cap 1 Structure: Enzymatically added using Vaccinia virus Capping Enzyme, GTP, S-adenosylmethionine, and 2'-O-methyltransferase. This cap mimics mammalian mRNA, increasing translation efficiency and reducing recognition by innate immune sensors such as RIG-I (Ranganathan 2020).
    • 5mCTP and ψUTP: 5-Methylcytidine and pseudouridine modifications stabilize the mRNA and suppress activation of Toll-like receptors and other pattern recognition receptors, thus reducing the induction of interferons and other inflammatory cytokines (Roach 2024).
    • Poly(A) Tail: Promotes ribosome recruitment and stabilizes mRNA in the cytoplasm, extending translational lifetime.
    • Buffer and Storage: Provided at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and stable at or below -40°C to prevent hydrolysis and preserve activity.

    Evidence & Benchmarks

    • 5mCTP/ψUTP-modified mRNAs show enhanced resistance to RNase-mediated degradation compared to unmodified transcripts (Roach 2024, Pace Digital Commons).
    • Cap 1 structure increases translation efficiency by up to 2-fold in mammalian cells, compared to Cap 0, under identical transfection conditions (Ranganathan 2020).
    • mCherry mRNA enables robust red fluorescence detectable by flow cytometry and microscopy for up to 48 hours post-transfection in vitro (internal benchmark).
    • Reporter mRNAs incorporating 5mCTP and ψUTP elicit significantly lower IFN-β secretion in primary human cells than unmodified controls (Roach 2024, Pace Digital Commons).
    • Poly(A)-tailed mRNAs demonstrate increased protein output compared to non-polyadenylated counterparts in eukaryotic systems (Leppek 2018).

    Applications, Limits & Misconceptions

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is designed for precise, transient expression of red fluorescent protein in a variety of systems:

    • Reporter gene in transfection and electroporation workflows.
    • Live-cell imaging for subcellular localization and dynamic tracking.
    • Benchmarking transfection efficiency and delivery vehicles (e.g., lipid nanoparticles, mesoscale nanoparticles).
    • Cell sorting and lineage tracing in primary and stem cell cultures.

    For a deep dive into advanced cell component positioning and molecular marker strategies, see EZ Cap™ mCherry mRNA: Next-Level Molecular Markers for Cell Component Positioning, which extends this article with mechanistic insight into subcellular visualization.

    Researchers interested in optimizing experimental parameters and troubleshooting expression should reference Optimizing Fluorescent Protein Expression with mCherry mRNA; this guide provides protocol-level insights not detailed here.

    Common Pitfalls or Misconceptions

    • The mRNA is not suitable for stable (long-term) genome integration; it supports only transient expression.
    • Unmodified mRNAs or those lacking Cap 1 structure may trigger stronger innate immune responses and rapid degradation.
    • Improper storage above -40°C can lead to significant loss of mRNA integrity and transfection efficacy.
    • Fluorescent signal persistence is limited by mRNA and protein half-life; expression rarely exceeds 72 hours post-transfection in dividing cells.
    • Product is not intended for direct in vivo therapeutic use without further formulation and safety evaluation.

    Workflow Integration & Parameters

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is compatible with both direct transfection and nanoparticle-based delivery workflows. For lipid or polymeric nanoparticle encapsulation, ensure mRNA is handled RNase-free and diluted in compatible buffer. Typical working concentrations range from 0.1–2 μg per transfection depending on cell type and assay sensitivity. The Cap 1 structure and modified nucleotides help maintain a high signal-to-noise ratio in reporter assays (Applied Workflows with mCherry mRNA). For best results, use freshly thawed aliquots and avoid repeated freeze-thaw cycles. Storage at ≤ -40°C in single-use aliquots maximizes stability.

    Conclusion & Outlook

    EZ Cap™ mCherry mRNA (5mCTP, ψUTP) provides an advanced, immune-evasive solution for transient reporter gene expression in mammalian systems. Its Cap 1 structure and nucleotide modifications enable reliable, persistent fluorescence for cell tracking and molecular studies. For full technical specifications, refer to the product page. This article updates prior protocol-focused content by providing a mechanism-centered benchmark and evidence review. As mRNA technologies evolve, such optimized constructs will remain pivotal for cell biology, especially for high-precision, non-integrative applications.